The Association Between Circulating Inflammatory Markers and Metabolic Syndrome in Korean Rural Adults
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives : This study was performed to investigate the associations between the metabolic syndrome (MetS) and inflammatory markers. Methods : This cross-sectional analysis was performed using data from 1578 Koreans aged 40-69 years residing in a rural area. We investigated associations between MetS and circulating high sensitivity C-reactive protein (hs-CRP), white blood cells (WBC) and adiponectin. MetS was defined using the criteria proposed by the National Cholesterol Education Program Adult Treatment Panel III (ATP-III). Results : Increased WBC counts and hs-CRP levels and decreased adiponectin levels were observed in subjects with MetS. WBC, hs-CRP and adiponectin levels linearly deteriorated with an increase in the number of MetS components (all ptrend <0.005). Finally, adjusted odds ratios (ORs) for the risk of MetS by increase/decrease in 3 inflammatory markers were calculated by multivariate logistic regression analyses. In terms of changes in inflammation markers, in men, the adjusted ORs (95% confidence interval) were 1.15 (1.01-1.31) for WBC, 1.64 (1.02-2.64) for hs-CRP, and 0.19 (0.08-0.45) for adiponectin, whereas corresponding adjusted ORs (95% CIs) in women were 1.27 (1.15-1.40), 0.98 (0.67-1.42), 0.09 (0.04-0.18), respectively. Conclusions : Serum adiponectin levels and WBC counts were found to be strongly associated with MetS in both sexes. However, hs-CRP lost its significance after adjusting for BMI and other inflammatory markers in women. This study shows that inflammatory response is associated with MetS in the Korean population. Further prospective studies are necessary to confirm the contribution made by inflammatory markers to the development of MetS.
Abstract
Objectives : This study was performed to investigate the associations between the metabolic syndrome (MetS) and inflammatory markers. Methods : This cross-sectional analysis was performed using data from 1578 Koreans aged 40-69 years residing in a rural area. We investigated associations between MetS and circulating high sensitivity C-reactive protein (hs-CRP), white blood cells (WBC) and adiponectin. MetS was defined using the criteria proposed by the National Cholesterol Education Program Adult Treatment Panel III (ATP-III). Results : Increased WBC counts and hs-CRP levels and decreased adiponectin levels were observed in subjects with MetS. WBC, hs-CRP and adiponectin levels linearly deteriorated with an increase in the number of MetS components (all ptrend <0.005). Finally, adjusted odds ratios (ORs) for the risk of MetS by increase/decrease in 3 inflammatory markers were calculated by multivariate logistic regression analyses. In terms of changes in inflammation markers, in men, the adjusted ORs (95% confidence interval) were 1.15 (1.01-1.31) for WBC, 1.64 (1.02-2.64) for hs-CRP, and 0.19 (0.08-0.45) for adiponectin, whereas corresponding adjusted ORs (95% CIs) in women were 1.27 (1.15-1.40), 0.98 (0.67-1.42), 0.09 (0.04-0.18), respectively. Conclusions : Serum adiponectin levels and WBC counts were found to be strongly associated with MetS in both sexes. However, hs-CRP lost its significance after adjusting for BMI and other inflammatory markers in women. This study shows that inflammatory response is associated with MetS in the Korean population. Further prospective studies are necessary to confirm the contribution made by inflammatory markers to the development of MetS.
참고문헌 (29)
- Ford ES, "Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey", JAMA, 287(3), pp.356~359 (2002)
- Matsushita K, "Comparison of circulating adiponectin and proinflammatory markers regarding their association with metabolic syndrome in Japanese men", Arterioscler Thromb Vasc Biol, 26(4), pp.871~876 (2006)
- Isomaa B, "Cardiovascular morbidity and mortality associated with the metabolic syndrome", Diabetes Care, 24(4), pp.683~689 (2001)
- Risk Factor and Life Expectancy Research Group, "Syndrome X and mortality: A populationbased study", Am J Epidemiol, 148(10), pp.958~966 (1998)
- Wellen KE, "Obesity-induced inflammatory changes in adipose tissue", J Clin Invest, 112(12), pp.1785~1788 (2003)
- Gonzaalez AS, "Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin", Eur J Clin Nutr, 60(6), pp.802~809 (2006)
- Lim S, "C-reactive protein level as an independent risk factor of metabolic syndrome in the Korean population", Diabetes Res Clin Pract, 70(2), pp.126~133 (2005)
- Kerner A, "Association between elevated liver enzymes and C-reactive protein: Possible hepatic contribution to systemic inflammation in the metabolic syndrome", Arterioscler Thromb Vasc Biol, 25(1), pp.193~197 (2005)
- Choi KM, "Serum adiponectin, interleukin- 10 levels and inflammatory markers in the metabolic syndrome", Diabetes Res Clin Pract, 75(2), pp.235~240 (2007)
- Targher G, "The white blood cell count: Its relationship to plasma insulin and other cardiovascular risk factors in healthy male individuals", J Intern Med, 239(5), pp.435~441 (1996)
- Ford ES, "The metabolic syndrome and Creactive protein, fibrinogen, and leukocyte count : Findings from the Third National Health and Nutrition Examination Survey", Atherosclerosis, 168(2), pp.351~358 (2003)
- Desai MY, "Association of body mass index, metabolic syndrome, and leukocyte count", Am J Cardiol, 79(6), pp.835~838 (2006)
- Weyer C, "Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia", J Clin Endocrinol Metab, 86(5), pp.1930~1935 (2001)
- Choi KM, "Serum adiponectin concentrations predict the development of type 2 diabetes and the metabolic syndrome in elderly Koreans", Clin Endocrinol, 61(1), pp.75~80 (2004)
- Matsuzawa Y, "Adiponectin and metabolic syndrome", Arterioscler Thromb Vasc Biol, 24(1), pp.29~33 (2004)
- 류소연, "농촌 지역 주민의 혈청 ferritin 수준과 대사증후군과의 관련성", 예방의학회지, 41(2), pp.115~120 (2008), 대한예방의학회
- Grundy SM, "American Heart Association, et al. Definition fo metabolic syndrome: Report of the National Heart, Lung, and Blood Institute", American Heart Association conference on scientific issues related to definition, 2004, pp.109(3), 433~438
- Lee SY, "Appropriate waist circumference cutoff points for central obesity in Korean adults", Diabetes Res Clin Pract, 75(1), pp.72~80 (2007)
- Nakanishi N, "Associations between white blood cell count and features of the metabolic syndrome in Japanese male office workers", Ind Health, 40(3), pp.273~277 (2002)
- Lohsoonthorn V, "Prevalence of metabolic syndrome and its relationship to white blood cell count in a population of Thai men and women receiving routine health examinations", Am J Hypertens, 19(4), pp.339~345 (2006)
- Ishizaka N, "Relationship between smoking, white blood cell count and metabolic syndrome in Japanese women", Diabetes Res Clin Pract, 78(1), pp.72~76 (2007)
- Festa A, "Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS)", Circulation, 102(1), pp.42~47 (2000)
- Makita S, "The association of C-reactive protein levels with carotid intima-media complex thickness and plaque formation in the general population", Stroke, 36(10), pp.2138~2142 (2005)
- Blackburn R, "Elevated Creactive protein constitutes an independent predictor of advanced carotid plaques in dyslipidemic subjects", Arterioscler Thromb Vasc Biol, 21(12), pp.1962~1968 (2001)
- Wang TJ, "Association of Creactive protein with caritid atherosclerosis in men and women: The Framingham Heart Study", Arterioscler Thromb Vasc Biol, 22(10), pp.1662~1667 (2002)
- Salas-Salvado J, "Plasma adiponectin distribution in a Mediterranean population and its association with cardiovascular risk factors and metabolic syndrome", Metabolism, 56(11), pp.1486~1492 (2007)
- Kumada M, "Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages", Circulation, 109(17), pp.2046~2049 (2004)
- Chen H, "diponectin stimulates production of nitric oxide in vascular endothelial cells", J Biol Chem, 278(45), pp.45021~45026 (2003)
- Torres JL, "Clinical use of high sensitivity C-reactive protein for the prediction of adverse cardiovascular events", Curr Opin Cardiol, 18(6), pp.471~478 (2003)